3-(2-Furyl)-1H-1,2,4-triazol-5-amine
CAS: 3663-61-4
Rif. 3D-FF125698
1g | Fuori produzione | ||
2g | Fuori produzione | ||
100mg | Fuori produzione | ||
250mg | Fuori produzione | ||
500mg | Fuori produzione |
Informazioni sul prodotto
- 1H-1,2,4-triazol-5-amine
- 3-(2-furanyl)-
- 1H-1,2,4-Triazol-3-amine, 5-(2-furanyl)-
- 1H-1,2,4-triazol-5-amine, 3-(2-furanyl)-
- 3-(2-Furanyl)-1H-1,2,4-triazol-5-amine
- 3-(Furan-2-yl)-1H-1,2,4-triazol-5-amine
- 3-Amino-5-(2-furyl)-1,2,4-triazole
- 3-Amino-5-(furan-2-yl)-1H-1,2,4-triazole
- 4H-1,2,4-triazol-3-amine, 5-(2-furanyl)-
- 5-(2-Furyl)-4H-1,2,4-triazol-3-amine
- Vedi altri sinonimi
- 5-(furan-2-yl)-4H-1,2,4-triazol-3-amine
- s-Triazole, 3-amino-5-(2-furyl)-
3-(2-Furyl)-1H-1,2,4-triazol-5-amine is a pharmacological agent that is used in the treatment of pulmonary hypertension. It has a nitric oxide donor activity and can be synthesized using 2-furyl nitration. This compound has been shown to inhibit adenosine receptors and block adenosine signaling. 3-(2-Furyl)-1H-1,2,4-triazol-5-amine has affinity for the A1 receptor with an IC50 of 0.5 μM and inhibits adenosine binding with an IC50 of 1 μM.
This drug also has a high degree of specificity for A2A receptors with an IC50 of 5 μM. 3-(2-Furyl)-1H-1,2,4-triazol-5-amine is active in vivo as well as in vitro.